HIV Infections: all 4,342 studies
Page 19 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV InfectionCompletedNCT02976259Phase 3
- Cape Town Young Women's Health CoOpCompletedNCT02974998Not applicable
- Safe Generations Plus: Swaziland PMTCT LTF StudyCompletedNCT02969161
- NC Young Women's CoOpTerminatedNCT02965014Not applicable
- Safety, PK and Antiviral Activity of PGT121 Monoclonal Antibody in HIV-uninfected and HIV-infected AdultsCompletedNCT02960581Phase 1
- Improving Outcomes in HIV Patients Using Mobile Phone Based Interactive Software SupportCompletedNCT02953080Not applicable
- Text Messaging Plus Motivational Interviewing in Promotion of Breastfeeding Among HIV-infected WomenCompletedNCT02949713Not applicable
- Advancing HIV Prevention and Linkage to Care Among MSM With GamificationCompletedNCT02946164Not applicable
- Dosing of Tenofovir and Efavirenz in Antiretroviral TherapyCompletedNCT02945163Phase 4
- Social Norms and Priming to Improve Adherence to Antiretroviral Therapy and Retention in CareCompletedNCT02938533Not applicable
- Mindful Living With Stress for Nurses Caring for HIV/AIDS Patients in ChinaStatus unknownNCT02936310Not applicable
- Optimization of Antiretroviral TherapyCompletedNCT02935075Phase 4
- Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected PatientsCompletedNCT02934022Not applicable
- Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)CompletedNCT02926456
- Duo Partnership Adherence Commitment TherapyCompletedNCT02925949Not applicable
- Study of Single IV Administration of P2G12Status unknownNCT02923999Phase 1
- Trauma Intervention for Affect Regulation, AIDS, and SubstancesCompletedNCT02923141Not applicable
- Rice Bran Supplementation in Treated HIV InfectionCompletedNCT02922907Not applicable
- Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor SettingsCompletedNCT02921516Not applicable
- Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal RingCompletedNCT02920827Phase 1
- Supporting Adolescents to Adhere - an Intervention Using Airtime Rewards Allocated by a Prize DrawingCompletedNCT02918838Not applicable
- MaxART: Early Access to ART for All in SwazilandCompletedNCT02909218Not applicable
- Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE)Status unknownNCT02904733Not applicable
- Chidamide in Combination With ART for Reactivation of the Latent HIV-1 ReservoirStatus unknownNCT02902185Phase 2/3
- Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible TabletCompletedNCT02893488Phase 1
- Innovative Behavioral Economics Incentives Strategies for HealthCompletedNCT02890459Not applicable
- Evaluation of an Integrated Economic Strengthening and HIV Prevention Program for Vulnerable Youth in South AfricaCompletedNCT02888678Not applicable
- Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular ImmunityCompletedNCT02886416
- Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy WomenCompletedNCT02875119Phase 1
- New Strategies to Assess Anal Cancer Risk In WomenCompletedNCT02873741
- A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy SubjectsCompletedNCT02859259Phase 1
- Exploratory Study of Cellular Reservoirs in Blood From HIV Infected PatientsCompletedNCT02858414Not applicable
- Impact of HIV Self-testing Among Female Sex Workers in Kampala, UgandaCompletedNCT02846402Not applicable
- Positive Connections: COPA2CompletedNCT02846350Not applicable
- 'HI-4-TU' Study: Health Improvement for Teen Ugandans StudyCompletedNCT02845284Not applicable
- Zambian Peer-Educators for HIV Self-Testing StudyCompletedNCT02827240Not applicable
- 3BNC117 and 10-1074 in HIV-infected IndividualsCompletedNCT02825797Phase 1
- 3BNC117 and 10-1074 in HIV Uninfected AdultsCompletedNCT02824536Phase 1
- Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary InterventionTerminatedNCT02818283Not applicable
- Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With MenActive, not recruitingNCT02816879Not applicable
- Intervention to Encourage HIV Testing and Counseling Among AdolescentsCompletedNCT02812329Phase 1
- Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating WomenCompletedNCT02808949Phase 1
- Absolute Bioavailability of BMS-626529 After Oral and Intravenous DosingCompletedNCT02805556Phase 1
- Factors Associated With Late HIV Diagnosis in Grampian: an Epidemiological StudyCompletedNCT02804724
- A Study to Evaluate the Effect of High Fat Meal on CabotegravirCompletedNCT02799264Phase 1
- Impact of ART Adherence on HIV Persistence and InflammationCompletedNCT02797093
- BRIDGE: Improving HIV Service Delivery for People Who Inject DrugsCompletedNCT02796027Not applicable
- Single and Repeated Dose Escalation Study of GSK2838232CompletedNCT02795754Phase 1
- Partners Demonstration Project of PrEP and ARTCompletedNCT02775929Phase 4
- Safety and Immunogenicity of a Vaccine Dendritic Cell-based Pulsed With Autologous Heat-inactivated in HIV-1 Infected PatientsCompletedNCT02767193Phase 1
- Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated VirusCompletedNCT02766049Phase 1/2
- Clinical Trial of Recombinant Adenovirus Type 5 AIDS VaccineStatus unknownNCT02762045Phase 1
- Adherence Connection for Counseling, Education, and SupportStatus unknownNCT02753049Not applicable
- Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node FibrosisCompletedNCT02750059Phase 2
- Liraglutide for HIV-associated Neurocognitive DisorderTerminatedNCT02743598Phase 4
- Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)CompletedNCT02741557Phase 1
- Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose CombinationsCompletedNCT02738931Phase 1
- Reducing Hazardous Alcohol Use & Human Immunodeficiency Virus (HIV) Viral LoadCompletedNCT02720237Not applicable
- Overcoming Barriers to HIV/AIDS Care and ART InitiationCompletedNCT02718456Not applicable
- A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176CompletedNCT02715479Phase 1
- Antiretroviral Regime for Viral Eradication in NewbornsCompletedNCT02712801Phase 4
- A Roll-over Observational Study for the Extended Follow-up of the Volunteers of the ISS T-003 TrialCompletedNCT02712489
- TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in PeruCompletedNCT02710032Not applicable
- The Lymphoid Tissue Pharmacology of Antiretroviral DrugsWithdrawnNCT02707926
- Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 InfectionTerminatedNCT02707900Phase 1
- Effectiveness of Nurse-delivered Care for Adherence/Mood in HIV in South AfricaCompletedNCT02696824Not applicable
- Addressing Psychosocial Comorbidities in HIV Treatment and PreventionCompletedNCT02696681Not applicable
- Cooperative Re-Engagement Controlled Trial (CoRECT)CompletedNCT02693145Not applicable
- Same-day ART Initiation Versus Standard of Care After Positive HIV-test Result in Rural LesothoCompletedNCT02692027Phase 3
- Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected AdultsCompletedNCT02685020Phase 1
- CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children)Status unknownNCT02674867Not applicable
- A Pilot Study of PrEP Acceptance Among Young Black MSMCompletedNCT02671591Not applicable
- Evaluation of Low-dose Darunavir in a Switch StudyCompletedNCT02671383Phase 3
- Dose Optimisation of Stavudine for the Treatment of HIV InfectionCompletedNCT02670772Phase 3
- A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/NaloxoneCompletedNCT02666001Phase 1
- Peer Education Program for HIV/AIDS Related Sexual Behaviors of Secondary School StudentsCompletedNCT02665091Not applicable
- Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity ProfilesCompletedNCT02663869
- HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-InfectionCompletedNCT02660905Phase 3
- Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject DrugsTerminatedNCT02659761Phase 4
- Metformin Immunotherapy in HIV InfectionCompletedNCT02659306Phase 1
- Evaluating the Safety, Tolerability, and Immunogenicity of a Prime-Boost Regimen of HIV-1 Nef/Tat/Vif, Env pDNA Vaccine Delivered Intramuscularly With Electroporation and HIV-1 rVSV envC Vaccine in Healthy, HIV-Uninfected AdultsCompletedNCT02654080Phase 1
- CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)CompletedNCT02652546Phase 1
- Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS PatientsCompletedNCT02651376Phase 1/2
- Impact of Hepatitis C Virus Therapy on Central Nervous System OutcomesCompletedNCT02650024
- Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected PatientsStatus unknownNCT02648516Phase 1/2
- PHAT Life: Preventing HIV/AIDS Among Teens in Juvenile JusticeCompletedNCT02647710Not applicable
- Community Intervention for HIV Testing & Care Linkage Among Young MSM in BulgariaCompletedNCT02639754Not applicable
- ART Drug Dosage Adjustment in HIV-infected PopulationCompletedNCT02632474Phase 4
- Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima PeruCompletedNCT02630082Not applicable
- Motivation Matters StudyCompletedNCT02627365Not applicable
- Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan AfricaCompletedNCT02626286Not applicable
- Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV InfectionCompletedNCT02614950Not applicable
- Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral TherapyCompletedNCT02611895Not applicable
- Taste Properties of HIV InhibitorCompletedNCT02608918Phase 1
- Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy VolunteersCompletedNCT02604004Phase 1
- WelTelOAKTREE: Text Messaging to Support Patients With HIV/AIDS in British ColumbiaCompletedNCT02603536Not applicable
- Cell Phone Technology Targeting ART and Naltrexone Adherence and Alcohol UseCompletedNCT02603471Not applicable
- Neural Correlates of Working Memory Training for HIV PatientsStatus unknownNCT02602418Not applicable
- Observational Study of HIV+ Deceased Donor Transplant for HIV+ RecipientsCompletedNCT02602262
- Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy AdultsCompletedNCT02599896Phase 1